These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2531913)

  • 1. Pancreatic pseudocyst fluid--a mixture of plasma proteins and pancreatic juice possessing a high proteolytic activity.
    Lasson A; Göransson J; Ohlsson K
    Scand J Clin Lab Invest; 1989 Sep; 49(5):403-12. PubMed ID: 2531913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic activity in pancreatic pseudocyst fluid.
    Lasson A; Genell S; Nilsson A
    Int J Pancreatol; 1994 Jun; 15(3):201-8. PubMed ID: 7930781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteolytic effect of pancreatic pseudocyst fluid on vessel walls.
    Lasson A; Jönsson K; Lore'n I; Sternby NH
    Int J Pancreatol; 1994 Aug; 16(1):23-9. PubMed ID: 7806911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic pseudocysts: a biochemical evaluation of proteases and protease inhibitors in plasma.
    Lasson A; Ohlsson K
    Scand J Gastroenterol; 1987 Apr; 22(3):355-61. PubMed ID: 3296135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of trypsin- and chymotrypsin-like proteases using p-nitroanilide substrates after sodium dodecyl sulphate polyacrylamide gel electrophoresis.
    Koivunen E
    J Chromatogr; 1989 May; 470(2):401-6. PubMed ID: 2768384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pathogenesis of the adult respiratory distress syndrome.
    McGuire WW; Spragg RG; Cohen AB; Cochrane CG
    J Clin Invest; 1982 Mar; 69(3):543-53. PubMed ID: 7037851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man.
    Lasson A; Laurell AB; Ohlsson K
    Scand J Gastroenterol; 1985 Apr; 20(3):335-45. PubMed ID: 2408321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.
    Harpel PC
    J Exp Med; 1973 Sep; 138(3):508-21. PubMed ID: 4269559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcapsular pancreatic pseudocyst of the kidney.
    Rauch RF; Korobkin M; Silverman PM; Dunnick NR
    J Comput Assist Tomogr; 1983 Jun; 7(3):536-8. PubMed ID: 6841726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous treatment of chronic pancreatitis and pancreatic pseudocyst.
    Munn JS; Aranha GV; Greenlee HB; Prinz RA
    Arch Surg; 1987 Jun; 122(6):662-7. PubMed ID: 3579580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
    Aasen AO; Ruud TE; Roeise O; Bouma BN; Stadaas JO
    Eur Surg Res; 1989; 21(1):1-10. PubMed ID: 2469582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-proteinase inhibitor in pure human pancreatic juice. Characterization of a complexed form in patients with chronic calcifying pancreatitis and its significance.
    Miszczuk-Jamska B; Guy O; Figarella C
    Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1597-601. PubMed ID: 6607205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual complication of chronic pancreatitis: a recanalized portal tree communicating with a pancreatic pseudocyst.
    Pedrazzoli S; Petrin P; De Marchi L; Miotto D; Bonadimani B; Costantino V
    Am J Gastroenterol; 1986 Aug; 81(8):698-701. PubMed ID: 3488677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
    Lasson A
    Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The separation of the substrates for plasma kallikrein and plasmin from a human kininogen.
    Mackay M; Combridge BS
    Br J Exp Pathol; 1970 Aug; 51(4):356-60. PubMed ID: 4098642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
    Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudocysts in chronic pancreatitis. Surgical results in 102 consecutive patients.
    Kiviluoto T; Kivisaari L; Kivilaakso E; Lempinen M
    Arch Surg; 1989 Feb; 124(2):240-3. PubMed ID: 2916944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating pancreatic pseudocyst and pancreatic necrosis using computerized tomography.
    Mainwaring R; Kern J; Schenk WG; Rudolf LE
    Ann Surg; 1989 May; 209(5):562-7; discussion 567-8. PubMed ID: 2705821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.